✦ LIBER ✦

TNF receptor-associated periodic syndrome (TRAPS): Description of a novelTNFRSF1Amutation and response to etanercept

✍ Scribed by Adriana A. Jesus; João B. Oliveira; Ivona Aksentijevich; Erika Fujihira; Magda M. S. Carneiro-Sampaio; Alberto J. S. Duarte; Clovis A. A. Silva

Book ID: 106121523
Publisher: Springer
Year: 2008
Tongue: English
Weight: 137 KB
Volume: 167
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s00431-008-0685-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TNF receptor-associated periodic syndrom

TNF receptor-associated periodic syndrome (TRAPS): A new cause of joint destruction?

✍ Yoland Schoindre; Antoine Feydy; Janine-Sophie Giraudet-Lequintrec; André Kahan; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Erratum to: Tumor necrosis factor recept

Erratum to: Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in Japan: a review of the literature

✍ Masakazu Washio,Teruaki Nakano,Yasushi Kawaguchi,Kae Takagi… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 95 KB

Successful treatment of a patient with t

Successful treatment of a patient with tumor necrosis factor receptor-associated periodic syndrome using a half-dose of etanercept

✍ Koichi Kusuhara; Takayuki Hoshina; Mitsumasa Saito; Masataka Ishimura; Hirosuke 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

Efficacy of etanercept in the tumor necr

Efficacy of etanercept in the tumor necrosis factor receptor–associated periodic syndrome: A prospective, open-label, dose-escalation study

✍ Ariel C. Bulua; Douglas B. Mogul; Ivona Aksentijevich; Harjot Singh; David Y. He 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 1 views

Role of tumour necrosis factor (TNF)-α a

Role of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis

✍ A. Caminero; M. Comabella; X. Montalban 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

Durability of Response to Rilonacept (IL

Durability of Response to Rilonacept (IL-1 Trap) in a Phase 3 Study of Patients with Cryopyrin-Associated Periodic Syndromes (CAPS): Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS)

✍ HOFFMAN, H; AMAR, N; CARTWRIGHT, R; KIVITZ, A; BELOMESTNOV, P; MELLIS, S; WEINST 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 46 KB